The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Filament BioSolutions, a New York-headquartered development-stage therapeutics company, has formed a collaboration with Ajinomoto Co., a Tokyo, Japan-based manufacturer of amino acids, to develop Filament’s lead product, FB-2710, an oral...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has launched a stand-alone serialization service for meeting a compliance deadline of February 2019 for certain requirements of the European Union Falsified...
Amphastar Pharmaceuticals, a Rancho Cucamonga, California-based specialty pharmaceutical company, has announced plans to expand the scope of its subsidiary, Amphastar Nanjing Pharmaceuticals (ANP).
Amphastar is a specialty pharmaceutical...
Fermion Oy, a Espoo, Finland-based, a manufacture of small-molecule active pharmaceutical ingredients (APIs), has commissioned a new manufacturing facility in Hanko, Finland, to replace an older manufacturing unit.
Fermion Oy manufacturers APIs...
Evonik has announced plans to invest EUR 35 million ($41 million) to expand its contract development and manufacturing (CDMO) capabilities in North America for controlled-release injectable formulations. The expansion of Evonik’s US and Canadian...
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, has formed a development and manufacturing pact with Immune Pharmaceuticals, a New York-headquartered clinical-stage biopharmaceutical company focused...
Abzena, a contract manufacturer of biologics and antibody drug conjugates, has signed manufacturing and bioconjugation agreements with Telix Pharmaceuticals, a Melbourne, Australia-based clinical-stage biopharmaceutical company. Telix specializes...
Bain Capital Private Equity, a private investment firm, has agreed to acquire DSM Sinochem Pharmaceuticals (DSP), a Singapore-headquartered producer of antibiotics, statins, and antifungals.
DSP is a 50/50 joint venture of Royal DSM, a life...
Bosch Packaging Technology has announced plans to sell its packaging machinery business.
“After intensively and thoroughly considering all its strategic options, the Bosch Group has decided to look for a buyer for its packaging machinery business...
Boehringer Ingelheim (BI) has completed a new filling line at its commercial manufacturing facility in Shanghai, China for its contract manufacturing business, BioXcellence. The new isolator-based fill/finish line is for GMP operations for aseptic...
Catalent has agreed to acquire Juniper Pharmaceuticals, a Boston, Massachusetts-headquartered specialty pharmaceutical company with contract development and manufacturing services, including its Nottingham, UK-based Juniper Pharma Services...
General Electric (GE) has announced plans to spin off GE Healthcare, its healthcare business, as a stand-alone company, following results from a strategic review. The plan is part of a larger reorganization and strategic alignment of the company....
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, has begun construction of an antibody-drug conjugate (ADC) service center in Wuxi, China.
The $20-million 6,000-square-meter facility will be...
MilliporeSigma has signed an agreement with HistoCyte Laboratories, a Tyne, UK-based cell-line technology company, to be the exclusive multinational distributor of HistoCyte’s portfolio of cell-line reference products for immunohistochemistry and...
Minakem, the contract development and manufacturing division of Minafin, a Mont-Saint-Guibert, Belgium-based fine chemicals producer, plans to open a new closed-controlled environment high-containment production facility in August 2018 at the...
